Matthew J Koch

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi request reprint Considerations in retransplantation of the failed renal allograft recipient
    Matthew J Koch
    Department of Medicine, Washington University School of Medicine at Barnes Jewish Hospital, St Louis, MO 63110, USA
    Adv Chronic Kidney Dis 13:18-28. 2006
  2. ncbi request reprint Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital, Washington University, One Barnes Jewish Hospital Plaza, St Louis, MO 63110, USA
    Transplantation 78:1198-203. 2004
  3. ncbi request reprint Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience
    Karen L Hardinger
    Department of Pharmacy Practice, University of Missouri Kansas City, Kansas City, MO 64108 2792, and Department of Medicine, Barnes Jewish Hospital at Washington University School of Medicine, St Louis, MO, USA
    Transplantation 81:1285-9. 2006
  4. pmc Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure
    Raghavender Boothpur
    Barnes Jewish Hospital, St Louis, MO, USA
    Am J Kidney Dis 55:141-3. 2010
  5. ncbi request reprint Current and future immunosuppressive strategies in renal transplantation
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Pharmacotherapy 24:1159-76. 2004
  6. ncbi request reprint Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation
    Karen L Hardinger
    Department of Pharmacy, Washington University School of Medicine, St Louis, MO, USA
    Transplantation 78:136-41. 2004
  7. ncbi request reprint Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital at Washington University, St Louis, MO, USA
    Am J Transplant 4:621-5. 2004

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Considerations in retransplantation of the failed renal allograft recipient
    Matthew J Koch
    Department of Medicine, Washington University School of Medicine at Barnes Jewish Hospital, St Louis, MO 63110, USA
    Adv Chronic Kidney Dis 13:18-28. 2006
    ..This review discusses available data and individual considerations that should be taken into account when retransplantation is proposed after failure of a primary allograft...
  2. ncbi request reprint Cyclosporine minimization and cost reduction in renal transplant recipients receiving a C2-monitored, cyclosporine-based quadruple immunosuppressive regimen
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital, Washington University, One Barnes Jewish Hospital Plaza, St Louis, MO 63110, USA
    Transplantation 78:1198-203. 2004
    ..This trial determines whether lower C2 levels could be targeted safely in de novo kidney transplant recipients under a quadruple regimen compared with a similar cohort monitored with trough (C0) levels...
  3. ncbi request reprint Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience
    Karen L Hardinger
    Department of Pharmacy Practice, University of Missouri Kansas City, Kansas City, MO 64108 2792, and Department of Medicine, Barnes Jewish Hospital at Washington University School of Medicine, St Louis, MO, USA
    Transplantation 81:1285-9. 2006
    ..This paper presents observational data of live-donor recipients who received Thymoglobulin induction and standard maintenance immunosuppressive therapy...
  4. pmc Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure
    Raghavender Boothpur
    Barnes Jewish Hospital, St Louis, MO, USA
    Am J Kidney Dis 55:141-3. 2010
    ..Jaw pain appears to be a hallmark symptom, and treatment with plasmapheresis and steroids relieves symptoms more rapidly than steroids alone...
  5. ncbi request reprint Current and future immunosuppressive strategies in renal transplantation
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Pharmacotherapy 24:1159-76. 2004
    ..Allograft tolerance and xenotransplantation are being studied, and the knowledge gained from the effort may help in the development of innovative strategies and new immunosuppressive agents...
  6. ncbi request reprint Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation
    Karen L Hardinger
    Department of Pharmacy, Washington University School of Medicine, St Louis, MO, USA
    Transplantation 78:136-41. 2004
    ..63%), less acute rejection (4% vs. 25%), and better graft survival. This article compares the safety and efficacy of Thymoglobulin versus Atgam induction through 5 years...
  7. ncbi request reprint Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing
    Karen L Hardinger
    Department of Pharmacy, Barnes Jewish Hospital at Washington University, St Louis, MO, USA
    Am J Transplant 4:621-5. 2004
    ..Tacrolimus given once daily in the morning, at 85% of the twice daily dose, provides safe and equivalent drug exposure to twice daily dosing. This convenient dosing schedule may help to increase compliance and lower costs...